Enterosgel paste for oral use container 405 g

Instructions for Enterosgel paste for oral use container 405 g

Composition

active ingredient: 100 g of paste contains 70 g of methylsilicic acid hydrogel;

Excipients: purified water.

Dosage form

Paste for oral use.

Main physicochemical properties: homogeneous pasty mass of white color, odorless.

Pharmacotherapeutic group

Enterosorbents. ATX code A07V S.

Pharmacological properties

Pharmacodynamics

Enterosgel is an inert organic silicon compound. When used, it exhibits a sorption effect. The drug effectively adsorbs medium-molecular toxic substances of exo- and endogenous origin, products of incomplete metabolism, incorporated radionuclides and naturally removes them from the body.

Enterosgel eliminates the manifestations of toxicosis, improves the function of the intestines, liver, kidneys, and normalizes blood and urine parameters.

Pharmacokinetics

By covering the mucous membrane of the stomach and intestines, Enterosgel protects it from erosive processes and helps increase local immunity.

Enterosgel is not absorbed from the intestines and does not undergo metabolic or chemical transformations.

Indication

As part of complex detoxification therapy for chronic renal failure; for toxic hepatitis, viral hepatitis A, B, liver cirrhosis and cholestasis of various etiologies; for enterocolitis, colitis, diarrhea, gastritis with low acidity, for alcohol and drug poisoning; for allergic and skin diseases (diathesis, neurodermatitis); for burn intoxication; purulent-septic and inflammatory processes accompanied by intoxication; toxicosis of pregnant women in the first half of pregnancy, in the complex therapy of intestinal dysbacteriosis.

Contraindication

Acute intestinal obstruction.

Interaction with other medicinal products and other types of interactions

The drug may reduce the effect of other drugs used with it. Simultaneous administration with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation.

The drug should not be used together with silver preparations.

Application features

Provided that the method of administration is followed (Enterosgel and medications are taken with an interval of 1.5-2 hours), the drug can be used in complex therapy with other medications and prophylactic agents, including prebiotics and probiotics (bifidum, lactobacilli), herbal preparations, adaptogens, and immunomodulators.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Use during pregnancy or breastfeeding

The drug can be used during pregnancy or breastfeeding. Use should be limited to pregnant women who are prone to constipation.

Method of administration and doses

Apply orally 3 times a day 1.5-2 hours before or 2 hours after meals or taking medications, drinking plenty of water.

For adults and children over 14 years of age, a single dose of the drug is 15 g (tablespoon), the daily dose is 45 g.

For children from birth to 5 years: a single dose of the drug is 5 g (teaspoon), daily dose - 15 g; from 5 to 14 years: a single dose - 10 g (dessert spoon), daily dose - 30 g.

The course of treatment is from 7 to 14 days.

In severe forms of the disease, a double single dose can be used during the first three days, and in the case of a chronic course of the disease (chronic renal failure), longer (up to 1 month) use of the drug is possible.

Children

The drug can be used in children from birth. For children under 2 years of age, a single dose of the drug can be mixed with a small amount of water before use.

Overdose

No cases of overdose have been described. In case of overdose, side effects may be aggravated.

Adverse reactions

When taking the drug, dyspeptic symptoms are possible. In the first days of taking the drug, constipation may develop. To prevent it, people prone to constipation are recommended to perform a cleansing enema at night or use laxatives (lactulose, sodium picosulfate) in the first two days of taking the drug.

Expiration date

3 years.

Storage conditions

Store at a temperature not exceeding 25 °C, do not freeze. After freezing, it loses its properties. After opening the package, store under the same conditions in a tightly closed container.

Keep out of reach of children.

Packaging

405 g per container.

Vacation category

Without a prescription.

Producer

PJSC KREOMA-PHARM.

Location of the manufacturer and its business address

03680, Ukraine, Kyiv, Radyshcheva St., 3.